In early June, FDA launched openFDA, an initiative to make it easier for web developers, researchers, and the public to access large, important public health datasets collected by the agency. Currently information from the FDA Adverse Event Reporting System is available, but the initiative will soon include datasets on drug labeling and recalls. [For more on FDA’s transparency initiative see IPQ June 28, 2014.]
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
